专利检索 ap:("Portola Pharmaceuticals, Inc.") AND inv:"GRETLER, Daniel, D." 第 1 页

1.

发明公开
INTRAVENOUS AND ORAL DOSING OF A DIRECT-ACTING AND REVERSIBLE P2Y12 INHIBITOR 审中-公开
标题翻译：一个直接作用的和可逆的P2Y12抑制剂的静脉内和口服剂量

公开(公告)号：EP2079464A2

公开(公告)日：2009-07-22

申请号：EP08747561.2

申请日：2008-05-02

申请人： Portola Pharmaceuticals, Inc.

发明人： GRETLER, Daniel, D. , CONLEY, Pamela, B. , ANDRE, Patrick , HUTCHALEELAHA, Athiwat , PHILLIPS, David, R. , PANDEY, Anjali , WOLIN, Huang , SCARBOROUGH, Robert, M.

IPC分类号： A61K31/216 , A61K31/517 , A61P7/02

CPC分类号： A61K31/517 , A61K31/216 , A61K2300/00

摘要： The invention provides methods and compositions for rapid and reversible inhibition of platelet aggregation in human subjects in need thereof by administering compounds of the formula: (I) alone or in combination with a second agent which can be aspirin or a thrombolytic agent.